SAGE POTASH CORP. IDENTIFIES LARGE-SCALE, HIGH-GRADE, US-BASED POTASH RESOURCE AND COMMENCES TRADING ON THE TSX-V UNDER THE SYMBOL "SAGE"

Investing News NetworkYour trusted source for investing success

paratek pharmaceuticals 2023

Biotech Update: Q3 2018 in Review
Biotech Investing

Biotech Update: Q3 2018 in Review

NASDAQ:PRTK
Biotech Investing

FDA Recommends Approval for Paratek’s Omadacycline

Pharmaceutical Investing

Paratek Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Omadacycline New Drug Applications

MARKETS

Markets
TSX19519.43+131.71
TSXV607.28+2.20
DOW32244.58+382.60
S&P 5003951.570.00
NASD11675.54+45.02
ASX6898.50-96.30

COMMODITIES

Commodities
Gold1964.65-11.82
Silver22.42-0.08
Copper4.02+0.07
Palladium1713.170.00
Platinum1087.260.00
Oil68.67+1.03
Heating Oil2.54-0.02
Natural Gas2.220.00

DOWNLOAD FREE REPORTS

EV Outlook 2023

2023 Lithium Outlook: Australia Edition

2023 Graphite Outlook: Australia Edition

2023 Battery Metals Outlook: Australia Edition

2023 Cobalt Outlook: Australia Edition

Browse more resource reports ≫

NEW! 2023 Tech Outlook Report

NEW! 2023 Cleantech Outlook Report

Emerging Tech Outlook 2023

NEW! 2023 AI Outlook Report

NEW! 2023 Crypto Outlook Report

Browse more technology reports ≫

NEW! 2023 Pharmaceuticals Outlook Report.

FREE 2023 Psychedelics Investor Report

NEW! 2023 Biotech Outlook Report.

NEW! 2023 Life Science Outlook Report.

Start Here – Investing in Pharma

Browse more life science reports ≫

BROWSE COMPANIES BY SECTOR

loader